Investor Alert

Alexion Pharmaceuticals Inc.



After Hours

 --Quotes are delayed by 20 min

Mar 5, 2021, 5:29 p.m.





0.00 0.00%


Volume 89,322

Quotes are delayed by 20 min


Previous close

$ 148.46

$ 150.10


+1.64 +1.10%

Day low

Day high




52 week low

52 week high




Annual Financials for Alexion Pharmaceuticals Inc.


Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Cash & Short Term Investments 1.29B1.47B1.56B2.79B3.07B
Cash Only 966M584.4M1.37B2.72B3.03B
Short-Term Investments 327M889.7M198.3M64M34.9M
Total Accounts Receivable 650M726.5M922.3M1.24B1.41B
Accounts Receivables, Net 650M726.5M922.3M1.24B1.41B
Accounts Receivables, Gross 650M726.5M922.3M1.24B1.41B
Bad Debt/Doubtful Accounts -----
Other Receivables -----
Inventories 375M460.4M472.5M627.6M775.7M
Finished Goods 215M307.1M350.7M405.6M-
Work in Progress 143M148.6M90.4M180.8M-
Raw Materials 17M4.7M31.4M41.2M-
Progress Payments & Other -----
Other Current Assets 260M292.9M426.4M418.3M578.6M
Miscellaneous Current Assets 260M292.9M426.4M418.3M578.6M
Total Current Assets 2.58B2.95B3.39B5.08B5.83B
20162017201820192020 5-year trend
Net Property, Plant & Equipment 1.04B1.33B1.47B1.37B1.46B
Property, Plant & Equipment - Gross 1.23B1.49B1.69B1.59B1.74B
Buildings 450M427.9M520.1M208.7M216.7M
Land & Improvements 10M9.6M9.6M9.6M9.6M
Computer Software and Equipment 123M141.5M144.8M155.1M171.9M
Other Property, Plant & Equipment 25M23.8M27.5M23.4M24.9M
Accumulated Depreciation 193M160.3M219.3M220.9M274.3M
Total Investments and Advances 69M16.6M300,00079.9M143.3M
Other Long-Term Investments 69M16.6M300,00079.9M143.3M
Long-Term Note Receivable -----
Intangible Assets 9.34B8.99B8.68B8.38B8.1B
Net Goodwill 5.04B5.04B5.04B5.04B5.1B
Net Other Intangibles 4.3B3.95B3.64B3.34B3B
Other Assets 230M295.6M396.4M349.1M362.9M
Tangible Other Assets 230M295.6M396.4M349.1M362.9M
Total Assets 13.25B13.58B13.93B17.54B18.1B

Liabilities & Shareholders' Equity

20162017201820192020 5-year trend
ST Debt & Current Portion LT Debt 167M167.4M343.8M145.5M176.1M
Short Term Debt --250M18.8M28.1M
Current Portion of Long Term Debt 167M167.4M93.8M126.7M148M
Accounts Payable 64M70.8M74.4M74M118.6M
Income Tax Payable -----
Other Current Liabilities 592M714.3M755.8M974.8M1.33B
Dividends Payable -----
Accrued Payroll 121M149.9M170.4M191.3M242.3M
Miscellaneous Current Liabilities 471M564.4M585.4M783.5M1.09B
Total Current Liabilities 823M952.5M1.17B1.19B1.62B
Long-Term Debt 2.89B2.72B2.86B2.61B2.66B
Long-Term Debt excl. Capitalized Leases 2.89B2.72B2.5B2.38B2.42B
Non-Convertible Debt 2.89B2.72B2.5B2.38B2.42B
Convertible Debt -----
Capitalized Lease Obligations --361M72.9M67.3M
Provision for Risks & Charges 129M168.9M183.2M192.4M299.4M
Deferred Taxes 396M365M391.1M(208.8M)(567.2M)
Deferred Taxes - Credit 396M365M391.1M2.08B1.63B
Deferred Taxes - Debit ---2.29B2.2B
Other Liabilities 323M483.1M155.6M192.7M231.5M
Other Liabilities (excl. Deferred Income) 323M483.1M155.6M192.7M231.5M
Deferred Income -----
Total Liabilities 4.56B4.69B4.77B6.27B6.45B
Non-Equity Reserves -----
Preferred Stock (Carrying Value) -----
Redeemable Preferred Stock -----
Non-Redeemable Preferred Stock -----
Common Equity (Total) 8.69B8.89B9.17B11.27B11.65B
Common Stock Par/Carry Value -----
Retained Earnings 1.82B2.24B2.33B4.64B5.24B
ESOP Debt Guarantee -----
Cumulative Translation Adjustment/Unrealized For. Exch. Gain (24M)(15.9M)(16.4M)(17.4M)(11.7M)
Unrealized Gain/Loss Marketable Securities (1M)200,0009.6M(100,000)-
Revaluation Reserves -----
Treasury Stock (1.14B)(1.6B)(1.69B)(2.11B)(2.62B)
Total Shareholders' Equity 8.69B8.89B9.17B11.27B11.65B
Accumulated Minority Interest -----
Total Equity 8.69B8.89B9.17B11.27B11.65B
Liabilities & Shareholders' Equity 13.25B13.58B13.93B17.54B18.1B
Link to MarketWatch's Slice.